secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K/A
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0000105770-25-000043
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma shareholders approve amended 2016 Omnibus Plan; share reserve increased by 2M
--------------------------------------------------------------------------------

- Shareholders approved amendment effective May 6, 2025; total share reserve increased to 7,500,000 from 5,500,000.
- Full value awards granted on/after May 6, 2025 count as 2.0 shares vs. 2.5 previously, reducing per-award dilution.
- Most awards subject to minimum 12-month vesting; up to 5% of shares exempt from this requirement.
- Non-employee director annual compensation cap raised to $800,000 (including cash).
- Plan term extended to May 6, 2035; awards outstanding upon termination remain in effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000043/0000105770-25-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000043/wst-20250506.htm
  HTML page:      https://secwatch.observer/filing/0000105770-25-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer